Anaphylaxis

·MeSH: Anaphylaxis

15 drugs in development·6 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
diphenhydramine	Miromatrix Medical Inc. (MIRO)
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
palforzia	Aimmune Therapeutics, Inc. (AIMT)

Phase 3(1)

Drug	Company
Anaphylm™	Aquestive Therapeutics, Inc. (AQST)

Preclinical(1)

Drug	Company
ht-kit	Hoth Therapeutics, Inc. (HOTH)

BLA Filed(1)

Drug	Company
anaphylm	Aquestive Therapeutics, Inc. (AQST)

Phase 1/Phase 2(9)

Drug	Company
a	Nasus Pharma Ltd (NSRX)
b	Nasus Pharma Ltd (NSRX)
c	Nasus Pharma Ltd (NSRX)
epinephrine autoinjector double dose	Nasus Pharma Ltd (NSRX)
epinephrine autoinjector single dose	Nasus Pharma Ltd (NSRX)
fmxin002 double dose	Nasus Pharma Ltd (NSRX)
fmxin002 double dose + nac	Nasus Pharma Ltd (NSRX)
fmxin002 single dose	Nasus Pharma Ltd (NSRX)
fmxin002 single dose + nac	Nasus Pharma Ltd (NSRX)

BioSniper tracks 15 drugs in development for Anaphylaxis across 6 companies.

There are 2 clinical trials targeting Anaphylaxis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.